IMMIX BIOPHARMA INC. - COMMON STOCK
2.4700
17-五月-24 14:59:51
15 分钟延时
股票
+0.2200
+9.78%
今日范围
2.2500 - 2.4746
ISIN
N/A
来源
NASDAQ
-
10 5月 2024 08:35:00 条件 Nasdaq GlobeNewswire
-
Immix Biopharma Awarded European Union Orphan Drug Designation for NXC-201 in Multiple Myeloma
29 4月 2024 08:39:00 条件 Nasdaq GlobeNewswire
-
Immix Biopharma on Track to Dose NXC-201 Patients in United States
18 4月 2024 08:32:00 条件 Nasdaq GlobeNewswire
-
20 3月 2024 08:46:00 条件 Nasdaq GlobeNewswire
-
Immix Biopharma Announces “Be Proactive in AL” AL Amyloidosis Awareness Initiative
05 3月 2024 08:35:00 条件 Nasdaq GlobeNewswire
-
Immix Biopharma 12 Month Review Progress Update
21 2月 2024 08:31:00 条件 Nasdaq GlobeNewswire
-
Immix Biopharma Announces Closing of $15 Million Public Offering of Common Stock
08 2月 2024 15:45:00 条件 Nasdaq GlobeNewswire
-
Immix Biopharma Awarded European Union Orphan Drug Designation for NXC-201 in AL Amyloidosis
07 2月 2024 08:37:00 条件 Nasdaq GlobeNewswire
-
Immix Biopharma Announces Pricing of $15 Million Public Offering of Common Stock
05 2月 2024 21:30:00 条件 Nasdaq GlobeNewswire
-
Immix Biopharma Announces Proposed Public Offering of Common Stock
05 2月 2024 14:20:11 条件 Nasdaq GlobeNewswire
-
24 1月 2024 07:35:00 条件 Nasdaq GlobeNewswire
-
18 12月 2023 08:39:00 条件 Nasdaq GlobeNewswire
-
Immix Biopharma to Present at the 2023 JMP Securities Hematology and Oncology Summit
30 11月 2023 08:46:00 条件 Nasdaq GlobeNewswire
-
22 11月 2023 08:19:00 条件 Nasdaq GlobeNewswire
-
21 11月 2023 08:46:00 条件 Nasdaq GlobeNewswire
-
21 11月 2023 08:46:00 条件 Nasdaq GlobeNewswire
-
06 11月 2023 08:12:00 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >